Alveo and Royal GD Advance Poultry Disease Testing Solutions

Rapid On-Site Testing Expands Beyond Bird Flu Detection

Alveo Technologies and Royal GD have announced new developments in their poultry testing partnership. Their goal is to create more rapid molecular tests for dangerous poultry diseases that can be used right on the farm.

This follows the success of their avian influenza test. The new tools will detect diseases that show similar signs to bird flu, including respiratory infections and other notifiable illnesses.

Alveo’s device uses patented IntelliSense™ technology to scan for disease DNA or RNA. It delivers accurate results in less than an hour through a smartphone app. This allows farmers to skip the lab wait and act fast to protect their birds.

Quick testing is important because many poultry diseases look the same at first. Without clear answers, producers may have to guess about treatments or containment steps. Alveo’s test changes that by offering fast answers right in the field.

Major poultry illnesses like Newcastle disease can cause huge losses. Fast detection means quicker isolation, better treatment, and fewer animals at risk. These new tools are built to help in regions where disease risks are high and growing.

Climate change and global trade have increased the spread of poultry diseases. Accurate, easy-to-use field tests are now more important than ever. Alveo and Royal GD are answering that need.